Your browser doesn't support javascript.
loading
TAOK1 is associated with neurodevelopmental disorder and essential for neuronal maturation and cortical development.
van Woerden, Geeske M; Bos, Melanie; de Konink, Charlotte; Distel, Ben; Avagliano Trezza, Rossella; Shur, Natasha E; Barañano, Kristin; Mahida, Sonal; Chassevent, Anna; Schreiber, Allison; Erwin, Angelika L; Gripp, Karen W; Rehman, Fatima; Brulleman, Saskia; McCormack, Róisín; de Geus, Gwynna; Kalsner, Louisa; Sorlin, Arthur; Bruel, Ange-Line; Koolen, David A; Gabriel, Melissa K; Rossi, Mari; Fitzpatrick, David R; Wilkie, Andrew O M; Calpena, Eduardo; Johnson, David; Brooks, Alice; van Slegtenhorst, Marjon; Fleischer, Julie; Groepper, Daniel; Lindstrom, Kristin; Innes, A Micheil; Goodwin, Allison; Humberson, Jennifer; Noyes, Amanda; Langley, Katherine G; Telegrafi, Aida; Blevins, Amy; Hoffman, Jessica; Guillen Sacoto, Maria J; Juusola, Jane; Monaghan, Kristin G; Punj, Sumit; Simon, Marleen; Pfundt, Rolph; Elgersma, Ype; Kleefstra, Tjitske.
Afiliación
  • van Woerden GM; Department of Neuroscience, Erasmus MC, Rotterdam, The Netherlands.
  • Bos M; The ENCORE Expertise Center for Neurodevelopmental Disorders, Erasmus MC, Rotterdam, The Netherlands.
  • de Konink C; Department of Clinical Genetics, Erasmus MC, Rotterdam, The Netherlands.
  • Distel B; Department of Human Genetics, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Nijmegen, The Netherlands.
  • Avagliano Trezza R; Department of Neuroscience, Erasmus MC, Rotterdam, The Netherlands.
  • Shur NE; Department of Neuroscience, Erasmus MC, Rotterdam, The Netherlands.
  • Barañano K; The ENCORE Expertise Center for Neurodevelopmental Disorders, Erasmus MC, Rotterdam, The Netherlands.
  • Mahida S; Department of Medical Biochemistry, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Chassevent A; Department of Neuroscience, Erasmus MC, Rotterdam, The Netherlands.
  • Schreiber A; Division of Genetics and Metabolism, Rare Disease Institute, Children's National Medical Center, Washington, District of Columbia, USA.
  • Erwin AL; Department of Neurogenetics, Kennedy Krieger Institute, Baltimore, Maryland, USA.
  • Gripp KW; Department of Neurogenetics, Kennedy Krieger Institute, Baltimore, Maryland, USA.
  • Rehman F; Department of Neurogenetics, Kennedy Krieger Institute, Baltimore, Maryland, USA.
  • Brulleman S; Genomic Medicine Institute, Cleveland Clinic, Cleveland, Ohio, USA.
  • McCormack R; Genomic Medicine Institute, Cleveland Clinic, Cleveland, Ohio, USA.
  • de Geus G; Division of Medical Genetics, Nemours/A.I. duPont Hospital for Children, Wilmington, Delaware, USA.
  • Kalsner L; Department of Neuroscience, Erasmus MC, Rotterdam, The Netherlands.
  • Sorlin A; Department of Neuroscience, Erasmus MC, Rotterdam, The Netherlands.
  • Bruel AL; Department of Neuroscience, Erasmus MC, Rotterdam, The Netherlands.
  • Koolen DA; Department of Neuroscience, Erasmus MC, Rotterdam, The Netherlands.
  • Gabriel MK; Departments of Neurology and Pediatrics, Connecticut Children's Medical Center and University of Connecticut School of Medicine, Farmington, Connecticut, USA.
  • Rossi M; UMR1231 GAD, Inserm, Université Bourgogne-Franche Comté, Dijon, France.
  • Fitzpatrick DR; Unité Fonctionnelle Innovation en Diagnostic génomique des maladies rares, FHU-TRANSLAD, CHU Dijon Bourgogne, Dijon, France.
  • Wilkie AOM; Centre de Référence maladies rares «Anomalies du Développement et syndromes malformatifs¼, Centre de Génétique, FHU-TRANSLAD, CHU Dijon Bourgogne, Dijon, France.
  • Calpena E; UMR1231 GAD, Inserm, Université Bourgogne-Franche Comté, Dijon, France.
  • Johnson D; Unité Fonctionnelle Innovation en Diagnostic génomique des maladies rares, FHU-TRANSLAD, CHU Dijon Bourgogne, Dijon, France.
  • Brooks A; Centre de Référence maladies rares «Anomalies du Développement et syndromes malformatifs¼, Centre de Génétique, FHU-TRANSLAD, CHU Dijon Bourgogne, Dijon, France.
  • van Slegtenhorst M; Department of Human Genetics, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Nijmegen, The Netherlands.
  • Fleischer J; Department of Clinical Diagnostics, Ambry Genetics, Aliso Viejo, California, USA.
  • Groepper D; Department of Clinical Diagnostics, Ambry Genetics, Aliso Viejo, California, USA.
  • Lindstrom K; MRC Human Genetics Unit, MRC IGMM, University of Edinburgh, Edinburgh, UK.
  • Innes AM; Clinical Genetics Group, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
  • Goodwin A; Oxford Craniofacial Unit, Oxford University Hospital NHS Foundation Trust, John Radcliffe Hospital, Oxford, UK.
  • Humberson J; Clinical Genetics Group, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
  • Noyes A; Oxford Craniofacial Unit, Oxford University Hospital NHS Foundation Trust, John Radcliffe Hospital, Oxford, UK.
  • Langley KG; Department of Clinical Genetics, Erasmus MC, Rotterdam, The Netherlands.
  • Telegrafi A; Department of Clinical Genetics, Erasmus MC, Rotterdam, The Netherlands.
  • Blevins A; Department of Pediatrics, SIU School of Medicine, Springfield, Illinois, USA.
  • Hoffman J; Department of Pediatrics, SIU School of Medicine, Springfield, Illinois, USA.
  • Guillen Sacoto MJ; Division of Genetics and Metabolism, Phoenix Children's Hospital, Phoenix, Arizona, USA.
  • Juusola J; Department of Medical Genetics and Alberta Children's Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
  • Monaghan KG; VCU Medical Center, Clinical Genetics Services, Richmond, Virginia, USA.
  • Punj S; Division of Pediatric Genetics, Department of Pediatrics, University of Virginia Medical Center, Charlottesville, Virginia, USA.
  • Simon M; GeneDx, Gaithersburg, Maryland, USA.
  • Pfundt R; GeneDx, Gaithersburg, Maryland, USA.
  • Elgersma Y; GeneDx, Gaithersburg, Maryland, USA.
  • Kleefstra T; GeneDx, Gaithersburg, Maryland, USA.
Hum Mutat ; 42(4): 445-459, 2021 04.
Article en En | MEDLINE | ID: mdl-33565190
ABSTRACT
Thousand and one amino-acid kinase 1 (TAOK1) is a MAP3K protein kinase, regulating different mitogen-activated protein kinase pathways, thereby modulating a multitude of processes in the cell. Given the recent finding of TAOK1 involvement in neurodevelopmental disorders (NDDs), we investigated the role of TAOK1 in neuronal function and collected a cohort of 23 individuals with mostly de novo variants in TAOK1 to further define the associated NDD. Here, we provide evidence for an important role for TAOK1 in neuronal function, showing that altered TAOK1 expression levels in the embryonic mouse brain affect neural migration in vivo, as well as neuronal maturation in vitro. The molecular spectrum of the identified TAOK1 variants comprises largely truncating and nonsense variants, but also missense variants, for which we provide evidence that they can have a loss of function or dominant-negative effect on TAOK1, expanding the potential underlying causative mechanisms resulting in NDD. Taken together, our data indicate that TAOK1 activity needs to be properly controlled for normal neuronal function and that TAOK1 dysregulation leads to a neurodevelopmental disorder mainly comprising similar facial features, developmental delay/intellectual disability and/or variable learning or behavioral problems, muscular hypotonia, infant feeding difficulties, and growth problems.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trastornos del Neurodesarrollo / Discapacidad Intelectual Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Animals / Humans Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trastornos del Neurodesarrollo / Discapacidad Intelectual Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Animals / Humans Idioma: En Año: 2021 Tipo del documento: Article